Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Author Correction: The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.

Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, Gonçalves BP, Björkman A, Ouedraogo AL, Morris U, Msellem M, Koepfli C, Mueller I, Tadesse F, Gadisa E, Das S, Domingo G, Kapulu M, Midega J, Owusu-Agyei S, Nabet C, Piarroux R, Doumbo O, Doumbo SN, Koram K, Lucchi N, Udhayakumar V, Mosha J, Tiono A, Chandramohan D, Gosling R, Mwingira F, Sauerwein R, Paul R, Riley EM, White NJ, Nosten F, Imwong M, Bousema T, Drakeley C, Okell LC.

Nat Commun. 2019 Jun 11;10(1):2644. doi: 10.1038/s41467-019-10790-0.

PMID:
31186429
2.

Correction to: Detection of Plasmodium falciparum infected Anopheles gambiae using near-infrared spectroscopy.

Maia MF, Kapulu M, Muthui M, Wagah MG, Ferguson HM, Dowell FE, Baldini F, Ranford-Cartwright L.

Malar J. 2019 Apr 17;18(1):137. doi: 10.1186/s12936-019-2776-0.

3.

The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.

Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, Gonçalves BP, Björkman A, Ouedraogo AL, Morris U, Msellem M, Koepfli C, Mueller I, Tadesse F, Gadisa E, Das S, Domingo G, Kapulu M, Midega J, Owusu-Agyei S, Nabet C, Piarroux R, Doumbo O, Doumbo SN, Koram K, Lucchi N, Udhayakumar V, Mosha J, Tiono A, Chandramohan D, Gosling R, Mwingira F, Sauerwein R, Paul R, Riley EM, White NJ, Nosten F, Imwong M, Bousema T, Drakeley C, Okell LC.

Nat Commun. 2019 Mar 29;10(1):1433. doi: 10.1038/s41467-019-09441-1. Erratum in: Nat Commun. 2019 Jun 11;10(1):2644.

4.

Detection of Plasmodium falciparum infected Anopheles gambiae using near-infrared spectroscopy.

Maia MF, Kapulu M, Muthui M, Wagah MG, Ferguson HM, Dowell FE, Baldini F, Ranford-Cartwright L.

Malar J. 2019 Mar 19;18(1):85. doi: 10.1186/s12936-019-2719-9. Erratum in: Malar J. 2019 Apr 17;18(1):137.

5.

Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders' meeting held in Entebbe, Uganda.

Elliott AM, Roestenberg M, Wajja A, Opio C, Angumya F, Adriko M, Egesa M, Gitome S, Mfutso-Bengo J, Bejon P, Kapulu M, Seager Z, Lutalo T, Nazziwa WB, Muwumuza A, Yazdanbakhsh M, Kaleebu P, Kabatereine N, Tukahebwa E.

AAS Open Res. 2018 Apr 18;1:2. doi: 10.12688/aasopenres.12841.1.

6.

Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya.

Njue M, Njuguna P, Kapulu MC, Sanga G, Bejon P, Marsh V, Molyneux S, Kamuya D.

Version 2. Wellcome Open Res. 2018 Oct 29 [revised 2018 Jan 1];3:39. doi: 10.12688/wellcomeopenres.14439.2. eCollection 2018.

7.

Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines.

Menon V, Kapulu MC, Taylor I, Jewell K, Li Y, Hill F, Long CA, Miura K, Biswas S.

Front Immunol. 2018 Jan 19;8:1998. doi: 10.3389/fimmu.2017.01998. eCollection 2017.

8.

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.

Taylor WR, Naw HK, Maitland K, Williams TN, Kapulu M, D'Alessandro U, Berkley JA, Bejon P, Okebe J, Achan J, Amambua AN, Affara M, Nwakanma D, van Geertruyden JP, Mavoko M, Lutumba P, Matangila J, Brasseur P, Piola P, Randremanana R, Lasry E, Fanello C, Onyamboko M, Schramm B, Yah Z, Jones J, Fairhurst RM, Diakite M, Malenga G, Molyneux M, Rwagacondo C, Obonyo C, Gadisa E, Aseffa A, Loolpapit M, Henry MC, Dorsey G, John C, Sirima SB, Barnes KI, Kremsner P, Day NP, White NJ, Mukaka M.

BMC Med. 2018 Jan 18;16(1):11. doi: 10.1186/s12916-017-0990-6.

9.

Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity.

Gonçalves BP, Kapulu MC, Sawa P, Guelbéogo WM, Tiono AB, Grignard L, Stone W, Hellewell J, Lanke K, Bastiaens GJH, Bradley J, Nébié I, Ngoi JM, Oriango R, Mkabili D, Nyaurah M, Midega J, Wirth DF, Marsh K, Churcher TS, Bejon P, Sirima SB, Drakeley C, Bousema T.

Nat Commun. 2017 Oct 26;8(1):1133. doi: 10.1038/s41467-017-01270-4.

10.

Detecting Malaria Hotspots: A Comparison of Rapid Diagnostic Test, Microscopy, and Polymerase Chain Reaction.

Mogeni P, Williams TN, Omedo I, Kimani D, Ngoi JM, Mwacharo J, Morter R, Nyundo C, Wambua J, Nyangweso G, Kapulu M, Fegan G, Bejon P.

J Infect Dis. 2017 Nov 27;216(9):1091-1098. doi: 10.1093/infdis/jix321.

11.

Evaluation of two lead malaria transmission blocking vaccine candidate antibodies in natural parasite-vector combinations.

Bompard A, Da DF, Yerbanga RS, Biswas S, Kapulu M, Bousema T, Lefèvre T, Cohuet A, Churcher TS.

Sci Rep. 2017 Jul 28;7(1):6766. doi: 10.1038/s41598-017-06130-1.

12.

Anti-microbial peptide gene expression during oral vaccination: analysis of a randomized controlled trial.

Simuyandi M, Kapulu M, Kelly P.

Clin Exp Immunol. 2016 Nov;186(2):205-213. doi: 10.1111/cei.12848. Epub 2016 Aug 29. Erratum in: Clin Exp Immunol. 2017 Feb;187(2):325.

13.

Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.

Kapulu MC, Da DF, Miura K, Li Y, Blagborough AM, Churcher TS, Nikolaeva D, Williams AR, Goodman AL, Sangare I, Turner AV, Cottingham MG, Nicosia A, Straschil U, Tsuboi T, Gilbert SC, Long CA, Sinden RE, Draper SJ, Hill AV, Cohuet A, Biswas S.

Sci Rep. 2015 Jun 11;5:11193. doi: 10.1038/srep11193.

14.

Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis.

Sinkala E, Kapulu MC, Besa E, Zyambo K, Chisoso NJ, Foster GR, Kelly P.

Liver Int. 2016 Jan;36(1):145-50. doi: 10.1111/liv.12891. Epub 2015 Jul 3.

PMID:
26058680
15.

Adjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian men.

Lisulo MM, Kapulu MC, Banda R, Sinkala E, Kayamba V, Sianongo S, Kelly P.

Clin Exp Immunol. 2014 Mar;175(3):468-75. doi: 10.1111/cei.12238.

16.

Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoes.

Williams AR, Zakutansky SE, Miura K, Dicks MD, Churcher TS, Jewell KE, Vaughan AM, Turner AV, Kapulu MC, Michel K, Long CA, Sinden RE, Hill AV, Draper SJ, Biswas S.

Int J Parasitol. 2013 Oct;43(11):869-74. doi: 10.1016/j.ijpara.2013.06.004. Epub 2013 Jul 18.

17.

Measuring the blockade of malaria transmission--an analysis of the Standard Membrane Feeding Assay.

Churcher TS, Blagborough AM, Delves M, Ramakrishnan C, Kapulu MC, Williams AR, Biswas S, Da DF, Cohuet A, Sinden RE.

Int J Parasitol. 2012 Oct;42(11):1037-44. doi: 10.1016/j.ijpara.2012.09.002. Epub 2012 Sep 27.

18.

Safety of live, attenuated oral vaccines in HIV-infected Zambian adults: oral vaccines in HIV.

Banda R, Yambayamba V, Lalusha BD, Sinkala E, Kapulu MC, Kelly P.

Vaccine. 2012 Aug 17;30(38):5656-60. doi: 10.1016/j.vaccine.2012.06.079. Epub 2012 Jul 10.

19.

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.

Cottingham MG, Carroll F, Morris SJ, Turner AV, Vaughan AM, Kapulu MC, Colloca S, Siani L, Gilbert SC, Hill AV.

Biotechnol Bioeng. 2012 Mar;109(3):719-28. doi: 10.1002/bit.24342. Epub 2011 Nov 6.

20.

Differential changes in expression of intestinal antimicrobial peptide genes during Ascaris lumbricoides infection in Zambian adults do not respond to helminth eradication.

Kapulu MC, Simuyandi M, Sianongo S, Mutale M, Katubulushi M, Kelly P.

J Infect Dis. 2011 May 15;203(10):1464-73. doi: 10.1093/infdis/jir035. Epub 2011 Feb 28.

Supplemental Content

Loading ...
Support Center